1.
Povero M, Pradelli L, Turco P, et al. Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey. Farmeconomia. Health Economics and Therapeutic Pathways. 2014;15(2):39-44. https://doi.org/10.7175/fe.v15i2.924